Article Information
History
- November 18, 2020.
Article Versions
- You are currently viewing Version 1 of this article (November 18, 2020 - 11:02).
- Version 2 (November 19, 2020 - 09:43).
- Version 3 (November 25, 2020 - 11:55).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Wiep van der Toorn1,2,
- Djin-Ye Oh3,
- Daniel Bourquain4,
- Janine Michel4,
- Eva Krause4,
- Andreas Nitsche4,
- Max von Kleist1,2,5,* and
- on behalf of the working group on SARS-CoV-2 Diagnostics at RKI
- 1,2Systems Medicine of Infectious Disease (P5) and Bioinformatics (MF1), Methodology and Research Infrastructure, Robert Koch Institute Berlin, Germany
- 3FG17 Influenza and other respiratory viruses, Department of Infectious Diseases, Robert Koch Institute Berlin, Germany
- 4ZBS1 Highly pathogenic viruses, Center for Biological Threats And Special Pathogens, Robert Koch Institute Berlin, Germany
- 5German COVID Omics Initiative (deCOI)
- ↵* Corresponding author; email: kleistm{at}rki.de